Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FITCATS: Fisetin for Carpal Tunnel Syndrome
NCT05416515Phase 2Completed
- Start
- Oct 2022
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of fisetin in carpal tunnel syndrome (CTS). Primary endpoint: Boston Carpal Tunnel Syndrome Questionnaire at 60 days. Started Oct 2022; status: completed.
02
Drugs
fisetin
03
Conditions
carpal tunnel syndrome (CTS)
Beyond the preview
Go deeper on NCT05416515.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05416515.